Belite Bio (BLTE) Assets (2021 - 2026)
Belite Bio (BLTE) reported Assets of $791.58 million for Q2 2026, up 406.1% from $156.41 million a year earlier but down 2.4% from the prior quarter.
Powered by 
Analysis
Belite Bio (BLTE) Assets (2021 - 2026) Analysis & Trends
At the end of FY2025, Belite Bio posted Assets of $780.56 million, up 413.1% from FY2024.
- Assets has increased for four consecutive years, with a four-year compound annual growth rate of 155.4% (FY2021 to FY2025).
- By year, Assets came in at $152.13 million in FY2024 (+60.7%), $94.64 million in FY2023 (+113.8%), $44.27 million in FY2022 (+141.3%) and $18.35 million in FY2021.
- Five-year quarterly Assets spans a low of $18.35 million in Q4 2021 and a high of $811.27 million in Q1 2026.
- Year over year, Assets has now increased in each of the last 11 quarters, with growth averaging 201.7% over the last eight quarters.
- Over the past five years, the year-over-year growth in Assets ranged from 18.9% (Q2 2023) to 413.1% (Q4 2025).
- Per Business Quant data, the three quarters before Q2 2026 came in at $811.27 million (Q1 2026), $780.56 million (Q4 2025) and $282.39 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Belite Bio | 6.53 Bn | 6.53 Bn | - | 791.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 791.58 Mn |
| Mar 31, 2026 | 811.27 Mn |
| Dec 31, 2025 | 780.56 Mn |
| Sep 30, 2025 | 282.39 Mn |
| Jun 30, 2025 | 156.41 Mn |
| Mar 31, 2025 | 164.20 Mn |
| Dec 31, 2024 | 152.13 Mn |
| Sep 30, 2024 | 115.82 Mn |
| Jun 30, 2024 | 118.43 Mn |
| Mar 31, 2024 | 101.15 Mn |
| Dec 31, 2023 | 94.64 Mn |
| Sep 30, 2023 | 57.60 Mn |
| Jun 30, 2023 | 60.70 Mn |
| Mar 31, 2023 | 39.82 Mn |
| Dec 31, 2022 | 44.27 Mn |
| Jun 30, 2022 | 51.06 Mn |
| Dec 31, 2021 | 18.35 Mn |
API Access
Belite Bio Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=BLTE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "BLTE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=BLTE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();